Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3043% below fair value
$4.89+0.08 (+1.66%)
Close on Nov 19, 2026Market cap $61.26MP/E 12.2Yield 3.78%
Lifevantage gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Lifevantage's gross profit for the twelve months ending Jun 30, 2026 was $141.61M, down 22.9% year over year. For fiscal 2026 it was $141.61M, down 22.9% from the year before. Over ten years it grew -2.0% a year on average. The highest annual figure on record is $194.95M in fiscal 2020.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $141.61M | -22.9% |
| FY2025 | Jun 30, 2025 | $183.67M | +15.7% |
| FY2024 | Jun 30, 2024 | $158.72M | -6.6% |
| FY2023 | Jun 30, 2023 | $170.01M | +1.0% |
| FY2022 | Jun 30, 2022 | $168.26M | -7.5% |
| FY2021 | Jun 30, 2021 | $181.99M | -6.6% |
| FY2020 | Jun 30, 2020 | $194.95M | +3.7% |
| FY2019 | Jun 30, 2019 | $187.99M | +11.7% |
| FY2018 | Jun 30, 2018 | $168.36M | +1.4% |
| FY2017 | Jun 30, 2017 | $166.03M | -3.8% |
| FY2016 | Jun 30, 2016 | $172.61M | +6.3% |
| FY2015 | Jun 30, 2015 | $162.33M | -10.2% |
| FY2014 | Jun 30, 2014 | $180.77M | +5.4% |
| FY2013 | Jun 30, 2013 | $171.54M | +58.6% |
| FY2012 | Jun 30, 2012 | $108.13M | +227.6% |
| FY2011 | Jun 30, 2011 | $33.00M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $33.04M | -25.0% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $34.54M | -27.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $36.21M | -33.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $37.82M | +0.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $44.05M | +13.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $47.33M | +24.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $54.57M | +34.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $37.72M | -8.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $38.91M | -9.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $38.07M | -11.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $40.56M | -3.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $41.18M | -1.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $43.15M | +3.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $43.12M | +6.9% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $41.90M | -1.4% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $41.83M | -4.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $41.61M | -7.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $40.35M | -5.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $42.51M | -12.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $43.79M | -3.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $45.00M | -9.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $42.75M | -9.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $48.82M | -4.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $45.43M | -3.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $49.92M | +7.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $46.98M | +0.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $51.01M | +5.5% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $47.04M | +1.4% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $46.46M | +1.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $46.74M | +12.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $48.37M | +19.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $46.41M | +14.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $45.96M | +10.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $41.64M | +13.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $40.37M | -2.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $40.39M | -12.3% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $41.75M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $36.77M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $41.45M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $46.06M | – |
See a number that looks wrong?